4.8 Article

TIRR inhibits the 53BP1-p53 complex to alter cell-fate programs

Journal

MOLECULAR CELL
Volume 81, Issue 12, Pages 2583-+

Publisher

CELL PRESS
DOI: 10.1016/j.molcel.2021.03.039

Keywords

-

Funding

  1. Gray Foundation Team Science Award
  2. DOD Ovarian Cancer Award [W81XWH150564/OC140632]
  3. Tina's Wish Foundation
  4. Claudia Adams Barr Program in Innovative Basic Cancer Research
  5. NIH [R01 CA132878, R35 GM136262]
  6. OCRA Liz Tilberis Award
  7. Swiss National Science Foundation [PP00P3_179057, 310030_197003]
  8. European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program [ERC-2016-STG 714326]
  9. [R01 CA208244]
  10. Swiss National Science Foundation (SNF) [PP00P3_179057, 310030_197003] Funding Source: Swiss National Science Foundation (SNF)

Ask authors/readers for more resources

TIRR inhibits the formation of the 53BP1-p53 complex by preventing the recruitment of 53BP1 to DSBs, leading to aberrant p53 activity and affecting p53-mediated cell-fate programs.
53BP1 influences genome stability via two independent mechanisms: (1) regulating DNA double-strand break (DSB) repair and (2) enhancing p53 activity. We discovered a protein, Tudor-interacting repair regulator (TIRR), that associates with the 53BP1 Tudor domain and prevents its recruitment to DSBs. Here, we elucidate how TIRR affects 53BP1 function beyond its recruitment to DSBs and biochemically links the two distinct roles of 53BP1. Loss of TIRR causes an aberrant increase in the gene transactivation function of p53, affecting several p53-mediated cell-fate programs. TIRR inhibits the complex formation between the Tudor domain of 53BP1 and a dimethylated form of p53 (K382me2) that is poised for transcriptional activation of its target genes. TIRR mRNA expression levels negatively correlate with the expression of key p53 target genes in breast and prostate cancers. Further, TIRR loss is selectively not tolerated in p53-proficient tumors. Therefore, we establish that TIRR is an important inhibitor of the 53BP1-p53 complex.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available